Biomarin Pharmaceuticals to buy Amicus Therapeutics for $4.8 billion, and the company's stock soars 30% ahead of the market

Zhitongcaijing · 1d ago
Biomarin Pharmaceuticals to buy Amicus Therapeutics for $4.8 billion, and the company's stock soars 30% ahead of the market